TYPE 2 diabetes, more commonly seen in adults, is rising among chil­dren in Trinidad and Tobago.Increasingly unheal­thy ...

Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...

Nearly 40 million Americans have diabetes, and nearly half of those are people who have Type 2 diabetes and are aged 65 or older. This population has a higher risk of ...

Recurrent wheezing is a serious morbidity, and it is estimated that about one-third of school-age children exhibit this symptom in the first five years of life. Recurrent wheezing in childhood is a ...

Abbott rolled out its first over-the-counter glucose sensor in the U.S. on Thursday, just over one week after Dexcom began selling its competing product. The device, called Lingo, is intended to be ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today ...

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...